APN News: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

ZIM Laboratories Limited (ZIM) – is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary  Novel Drug Delivery Solutions (NDDS).

Promoted by Technocrat Dr. Anwar Daud, the company has a Unique R&D focused business model helping customers with product development, co-development, out licensing, manufacturing, supplies and marketing support with a strong IP base – 26 inventions with 53 patent filings and 174 clients across 45 countries.

Original Article 

Popular posts from this blog

ZIM Labs’ Dr. Nidhi Sapkal addressed 2nd Annual Innogen India Summit 2017

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Serves Local Education Institute in Sanitation